day 2: track 2, patient’s role, dave leventhal (pfizer) jane larkindale, jeffrey sherman,
Published 8 years ago • 183 plays • Length 41:39Download video MP4
Download video MP3
Similar videos
-
19:19
let's get vascular: part ii
-
3:08:36
evm virtual interactive: day 2 - various
-
1:54
diagnosing type 2 diabetes
-
7:36
introducing remission - type 2 diabetes
-
1:46
a4m 30th annual spring congress: module v with james lavalle, rph
-
1:12
vascular medicine: a companion to braunwald's heart disease, 2nd edition
-
0:31
adrenalin ver2
-
5:42
exploring car-t cell therapy in multiple sclerosis: what you need to know
-
5:28
patient instruction for venous ablation
-
4:31
diagnosis of type 2 diabetes
-
6:22
conavi medical unveils next-gen dual-modality catheter for cardiac interventions
-
2:37
the importance of secondary cancer screening programs in hodgkin lymphoma survivors
-
1:07
promising investigational car-t approaches for myeloma: dual-targeted car-t products
-
1:46
assessing financial toxicity of car-t therapy in myeloma and improving access to this treatment
-
3:04
the logistical challenges of car t-cell therapy in non-hodgkin lymphoma
-
1:35
key predictors of success when administering car-t for dlbcl
-
0:53
glp-1 agonists and sglt-2 inhibitors for treating adults with scd and nephropathy
-
2:25
a phase ii adaptive study of dasatinib and inotuzumab-based induction for newly diagnosed ph all
-
2:43
24-hour urine testing does not add value to multiple myeloma response assessments
-
5:11
the cardiac wire show - circle cardiovascular imaging's cardiac ct expansion
-
4:40
can a continuous glucose monitor (cgm) be used to improve skin health and appearance?